Sudarshan Sukhani of s2analytics.com recommends exiting Natco Pharma and advises buying Glenmark Pharma, Dr Reddy's Laboratories and Sun Pharma at lower levels.
Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Ideally you want to get out of Natco Pharma. The stock has been moving sideways for may be about four months and it can move sideways again, it is more of a fundamental call. My chart suggests that Natco Pharma can go into a consolidation and correction. This is also more of a fundamental call."
Disclosure: Analyst does not have any positions in the stock.
Exclusive offer: Use code "BUDGET2020" and get Moneycontrol Pro's Subscription for as little as Rs 333/- for the first year.